Nothing Special   »   [go: up one dir, main page]

Ohnuma et al., 2007 - Google Patents

Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1

Ohnuma et al., 2007

View HTML @Full View
Document ID
12939350386173825906
Author
Ohnuma K
Uchiyama M
Yamochi T
Nishibashi K
Hosono O
Takahashi N
Kina S
Tanaka H
Lin X
Dang N
Morimoto C
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

CD26 is a widely distributed 110-kDa cell surface glycoprotein with an important role in T- cell costimulation. We demonstrated previously that CD26 binds to caveolin-1 in antigen- presenting cells, and following exogenous CD26 stimulation, Tollip and IRAK-1 disengage …
Continue reading at www.jbc.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means

Similar Documents

Publication Publication Date Title
Ohnuma et al. Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
Lo et al. Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT
Gaggero et al. Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor
Ditsworth et al. Activation of poly (ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus
Xing et al. The protein kinase KSR interacts with 14-3-3 protein and Raf
Vonakis et al. The unique domain as the site on Lyn kinase for its constitutive association with the high affinity receptor for IgE
Cao et al. A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase
Grawunder et al. Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V (D) J recombination and DNA double-strand break repairin vivo
Wardenburg et al. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function
Wilkinson et al. Emerin interacts in vitro with the splicing‐associated factor, YT521‐B
Eissmann et al. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244)
Heyeck et al. Lck phosphorylates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity
Pagano et al. Sec24 proteins and sorting at the endoplasmic reticulum
Wanschers et al. C7orf30 specifically associates with the large subunit of the mitochondrial ribosome and is involved in translation
Timchenko et al. Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/enhancer-binding protein β in old liver
Olsson et al. CTLA-4 ligation suppresses CD28-induced NF-κB and AP-1 activity in mouse T cell blasts
Marie-Cardine et al. Molecular interaction between the Fyn-associated protein SKAP55 and the SLP-76-associated phosphoprotein SLAP-130
Weil et al. Induction of the NF-κB cascade by recruitment of the scaffold molecule NEMO to the T cell receptor
Mousseau et al. PILRα, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRβ
Zhong et al. Control of T lymphocyte signaling by Ly108, a signaling lymphocytic activation molecule family receptor implicated in autoimmunity
Gary-Gouy et al. The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling
Vouret-Craviari et al. Post-translational and Activation-dependent Modifications of the G Protein-coupled Thrombin Receptor (∗)
Meyer et al. CD96 interaction with CD155 via its first Ig-like domain is modulated by alternative splicing or mutations in distal Ig-like domains
Simarro et al. SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9
Mukhopadhyay et al. Glycodelin A, not glycodelin S, is apoptotically active: Relevance of sialic acid modification